Stockreport

Monte Rosa CEO Sells $141K in Stock Amid 300% Surge and Recent Capital Raise [Globe and Mail, The (Toronto, Canada)]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF The sale represented 1.30% of their direct common stock holdings, reducing their directly held common shares from 613,471 to 605,471. All shares were sold from direct [Read more]